Madrigal Pharmaceuticals, Inc.

CIK 1673226 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Madrigal Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Dec 12, 2025SCHEDULE 13D/A0001104659-25-120702
Dec 12, 2025SCHEDULE 13D/A0001104659-25-120703
Aug 1, 2016SC 13D0001193125-16-666367
Aug 1, 2016SC 13D0001193125-16-666370
Jul 29, 2016SC 13D0001193125-16-664791
Apr 28, 2016D0001673226-16-000001
Apr 28, 2016SC 13D0001193125-16-560394